Multiple oncogenic pathway signatures show coordinate expression patterns in human prostate tumors
about
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaReverse phase protein arrays in signaling pathways: a data integration perspectiveSRC: marker or actor in prostate cancer aggressivenessCrosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathwaysGSVA: gene set variation analysis for microarray and RNA-seq data.Using large-scale molecular data sets to improve breast cancer treatment.Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells.Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.Targeting monoamine oxidase A in advanced prostate cancer.Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer.Cyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikis.Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer.Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Identification of a gene expression signature common to distinct cancer pathwaysNovel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures.Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer.Biological and functional analysis of statistically significant pathways deregulated in colon cancer by using gene expression profilesMetabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer.Modeling the Genetic Regulation of Cancer Metabolism: Interplay between Glycolysis and Oxidative Phosphorylation.Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancerSimultaneous inhibition of aryl hydrocarbon receptor (AhR) and Src abolishes androgen receptor signaling.Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer.Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis.Pan-urologic cancer genomic subtypes that transcend tissue of origin.Increased Notch signalling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells.A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions.Gene set enrichment analysis highlights different gene expression profiles in whole blood samples X-irradiated with low and high doses.Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).Pan-cancer molecular classes transcending tumor lineage across 32 cancer types, multiple data platforms, and over 10,000 cases.A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.
P2860
Q24597256-16458DB4-0BE1-4AE5-B721-FDC4DED39D70Q26799716-F0B7FA12-680A-468F-BC60-5C623FD11794Q27012541-DA075AF7-9F93-48D3-82E2-620842DEA8D0Q28487884-04F407D6-F0B7-4D6B-8F59-A4F34064F868Q30586230-E2292F92-90F7-4146-A37F-249AD8767890Q30656126-D37254A5-0385-40B9-9D27-5FF76819BDF9Q33494984-465549E9-FB4C-4717-9FA1-71204271A738Q33612477-6B3C63C5-3D7E-4012-A0B7-5CCDD02D280DQ34154664-AF88A3E6-790B-4EEE-82A3-857BE6742A59Q34365668-2077012D-1223-45F6-A89A-45B2D9E0B305Q34548034-21C8CE9A-F593-4F27-A5F5-A9C03D43E950Q34764094-4EA6F003-40CF-4707-83C5-5D3D1D837A9EQ35140092-C84758A4-1C3B-46E4-AC1C-BF789C440973Q35873154-CDDFF3F8-53BE-41DB-9F12-80CD12C55A4FQ35971152-FD933F6D-7B56-4FE9-ADA6-58DD90C08DABQ36580194-EA909603-1A6E-49F1-AB1D-3CE06A4C34B9Q36732781-69FBB960-9948-48CD-B922-5625683224F5Q36938166-3B1A923C-9B98-4B31-A951-E49652552646Q38615085-D3EFA56C-EE50-47BD-AA55-F94D388A7E6EQ38959435-3C0A1FDC-7544-4336-8837-C8B9191D5B8EQ39541646-216276B5-BC1F-44DC-8F28-EE536FCCB2D9Q40975913-A6935E86-2CD1-4F74-85E9-3469D3F3336AQ41069547-5CCCE562-5585-4666-9495-D8CD18ADF699Q41125664-40FAC5B6-1DF0-48F7-A11C-AD274739D0E4Q41243664-850A7B43-B09E-412E-92FE-3EB10B99C73BQ41995792-4DDE1322-B912-4520-8847-9362E22D1900Q43246314-AAADE114-6772-44F2-BE9C-37919EE33F2EQ45089227-B8E25A75-8CCE-4D3C-8904-8DE3C97529B5Q46216934-C1FD86AD-13BC-4D40-A31D-44B9A604A51DQ50027342-E4BECC13-2B3B-4BE7-ACA3-450E6C9AA056Q50989823-70F4ACDF-34EF-44E5-831D-8BBB6D1CC6FE
P2860
Multiple oncogenic pathway signatures show coordinate expression patterns in human prostate tumors
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Multiple oncogenic pathway sig ...... terns in human prostate tumors
@ast
Multiple oncogenic pathway sig ...... terns in human prostate tumors
@en
Multiple oncogenic pathway sig ...... erns in human prostate tumors.
@nl
type
label
Multiple oncogenic pathway sig ...... terns in human prostate tumors
@ast
Multiple oncogenic pathway sig ...... terns in human prostate tumors
@en
Multiple oncogenic pathway sig ...... erns in human prostate tumors.
@nl
prefLabel
Multiple oncogenic pathway sig ...... terns in human prostate tumors
@ast
Multiple oncogenic pathway sig ...... terns in human prostate tumors
@en
Multiple oncogenic pathway sig ...... erns in human prostate tumors.
@nl
P2860
P1433
P1476
Multiple oncogenic pathway sig ...... terns in human prostate tumors
@en
P2093
Chad J Creighton
P2860
P356
10.1371/JOURNAL.PONE.0001816
P407
P577
2008-03-19T00:00:00Z